Transforming GI Health Through Innovation
Targeted Therapies for Pancreatitis & Inflammatory Bowel Disease
Cibus Therapeutics is advancing next-generation small-molecule treatments that address the root causes of gastrointestinal inflammation. Backed by science, driven by compassion—our work is redefining what’s possible in GI care.
About Cibus Therapeutics
Cibus Therapeutics is a clinical-stage biopharmaceutical startup company innovating at the forefront of gastrointestinal healthcare. Headquartered in Stanford Research Park (Palo Alto, California), we are located in the neighborhood of biomedical innovation and talent. Our company is focused on developing advanced small-molecule therapies that target the complex inflammatory pathways in pancreatitis and inflammatory bowel disease (IBD). Our multidisciplinary team brings together expertise in translational science, clinical development, and patient care to address significant gaps in current treatment options. Through a commitment to science, collaboration, and compassion, we are working to redefine the future of GI disease management and improve lives around the world.
Advancing targeted therapies for gastrointestinal diseases.
1. Pancreatitis
We’re developing the first targeted therapy to reduce inflammation and halt disease progression in chronic pancreatitis.
2. Ulcerative Colitis
Our research focuses on safer, more effective treatments for ulcerative colitis, a serious form of IBD.
3. Precision Therapeutics
Using small molecules, we target key inflammatory pathways to treat GI diseases with higher precision and fewer side effects.
4. Research-Driven Impact
We bridge science and patient needs to address gaps in current GI disease treatment options.
Advancing targeted therapies for gastrointestinal diseases.
1. Pancreatitis
We’re developing the first targeted therapy to reduce inflammation and halt disease progression in chronic pancreatitis.
2. Ulcerative Colitis
Our research focuses on safer, more effective treatments for ulcerative colitis, a serious form of IBD.
3. Precision Therapeutics
Using small molecules, we target key inflammatory pathways to treat GI diseases with higher precision and fewer side effects.
4. Research-Driven Impact
We bridge science and patient needs to address gaps in current GI disease treatment options.
Be Part of the Change
Help us shape the future of gastrointestinal health. Whether you’re a researcher, clinician, patient advocate or investor, let’s work together to drive meaningful progress.
Turning Scientific Discovery into Life-Changing Therapies for GI Patients
What sets us apart?
At Cibus Therapeutics, we combine scientific rigor with a deep focus on gastrointestinal diseases, developing targeted therapies that address the root causes of chronic conditions like pancreatitis and ulcerative colitis. Our commitment to innovation is matched by a patient-first mindset, ensuring that our research translates into real-world impact. By collaborating with global experts and advocacy groups, we accelerate progress and deliver meaningful solutions where they’re needed most.
Our Process
From Questions to Solutions
01
Scientific Discovery
We begin with deep biological research to identify key inflammatory mechanisms driving chronic pancreatitis and IBD.
02
Preclinical & Clinical Development
Through rigorous testing and trials, we refine promising molecules into safe, effective treatments ready for patients.
03
Patient-Centric Innovation
We collaborate with clinicians, researchers, and advocacy groups to ensure our therapies meet real patient needs and improve lives.
What we’re working on right now
We’re actively advancing breakthrough therapies for chronic pancreatitis and IBD—bringing science closer to real-world impact for patients.
Advancing Novel Therapies
Developing a small-molecule drug to target key inflammatory pathways in chronic pancreatitis and ulcerative colitis.
Clinical-Stage Development
Our lead candidate is in clinical trials, focused on validating safety, efficacy, and long-term outcomes.
Deepening Scientific Insights
We’re expanding our understanding of GI inflammation to guide and refine future therapies.
Join the Science Movement
Advancing healthcare with innovative treatments, from gene therapy to the latest medical breakthroughs
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
